Sarepta went to $1 BILLION valuation after positive phase 2 results so why not ANP too ? that would mean around $2.20 per share for ANP .Whatever its the HOTTEST DMD GEM out there . STRONG BUY
Sarepta eyes multiple sclerosis gene therapy, page-13
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $41.71K | 393.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 385399 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 217753 | 2 |
View Market Depth
| Last trade - 13.38pm 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |